Ngam Advisors L.P. reduced its position in shares of IMS Health Holdings Inc. (NYSE:IMS) by 8.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 270,132 shares of the company’s stock after selling 25,973 shares during the period. Ngam Advisors L.P.’s holdings in IMS Health Holdings were worth $8,466,000 as of its most recent filing with the SEC.

Other large investors have also recently made changes to their positions in the company. Brahman Capital Corp. purchased a new stake in shares of IMS Health Holdings during the second quarter worth approximately $182,918,000. Farallon Capital Management LLC increased its position in IMS Health Holdings by 107.0% in the second quarter. Farallon Capital Management LLC now owns 6,347,206 shares of the company’s stock worth $160,965,000 after buying an additional 3,281,134 shares during the period. Janus Capital Management LLC increased its position in IMS Health Holdings by 56.2% in the second quarter. Janus Capital Management LLC now owns 7,289,684 shares of the company’s stock worth $184,864,000 after buying an additional 2,622,297 shares during the period. Steinberg Asset Management LLC bought a new position in IMS Health Holdings during the second quarter worth approximately $20,995,000. Finally, Neuberger Berman Group LLC bought a new position in IMS Health Holdings during the third quarter worth approximately $25,934,000. 90.25% of the stock is currently owned by institutional investors.

Institutional Ownership by Quarter for IMS Health Holdings (NYSE:IMS)

Shares of IMS Health Holdings Inc. (NYSE:IMS) remained flat at $31.34 on Tuesday. IMS Health Holdings Inc. has a 52-week low of $22.36 and a 52-week high of $31.34. The firm’s 50 day moving average is $31.34 and its 200-day moving average is $28.83.

WARNING: “IMS Health Holdings Inc. (IMS) Position Decreased by Ngam Advisors L.P.” was posted by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are accessing this article on another domain, it was stolen and republished in violation of U.S. & international copyright & trademark law. The correct version of this article can be viewed at https://www.thecerbatgem.com/2016/11/29/ims-health-holdings-inc-ims-position-decreased-by-ngam-advisors-l-p.html.

IMS has been the topic of a number of recent analyst reports. Zacks Investment Research raised shares of IMS Health Holdings from a “hold” rating to a “buy” rating and set a $34.00 target price on the stock in a research report on Wednesday, September 28th. TheStreet downgraded shares of IMS Health Holdings from a “buy” rating to a “hold” rating in a research report on Monday, August 29th. Three analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $30.71.

About IMS Health Holdings

IMS Health Holdings, Inc (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company’s data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community.

5 Day Chart for NYSE:IMS

Receive News & Stock Ratings for IMS Health Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMS Health Holdings Inc. and related stocks with our FREE daily email newsletter.